In March 2025, the company introduced new ideas to get a immediate-to-customer featuring of its Wegovy weight loss drug. The company established a new pharmacy, termed NovoCare, which would charge prospects $499 each month for use of the drug, under 50 % the expense of the drug as a result of other pharmaceutical distribution networks.[fifty three]